Study Stopped
no patients recruited
HyGIeaCare Procedure for Chronic Constipation
Evaluation of the HyGIeaCare Procedure for Patients With Chronic Constipation
1 other identifier
interventional
N/A
1 country
1
Brief Summary
To assess the safety and clinical effectiveness of using the FDA cleared HyGIeaCare System to relieve constipation in patients not responding to standard laxative treatment. Each patient will serve as their own control by comparing their bowel habits in a diary 4 weeks prior to colon irrigation to the bowel habits in their diary 4 weeks post colon irrigation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Mar 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 30, 2017
CompletedFirst Posted
Study publicly available on registry
November 8, 2017
CompletedStudy Start
First participant enrolled
March 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2019
CompletedSeptember 23, 2019
March 1, 2019
1 year
October 30, 2017
September 20, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Change in number of BMs
Change in the number of bowel movements per week from the baseline period (4 weeks) to the four weeks of the post-HyGIeaCare period.
8 weeks
Secondary Outcomes (2)
Change in constipation score and discomfort score (GISSI)
8 weeks
Change in rescue medications used
8 weeks
Study Arms (1)
pre colon irrigation diaries followed by post diaries
EXPERIMENTAL4 week bowel movement and rescue medication diaries will be compared to same diaries used 4 weeks after the colon irrigation procedure
Interventions
Study is to compare bowel movement patterns before and after colon irrigation.
Eligibility Criteria
You may qualify if:
- Patient has chronic constipation according to Rome III criteria
- Patient has not experienced relief of symptoms following treatment with available therapies (osmotic and stimulant laxatives) for at least one month at recommended doses.
You may not qualify if:
- Patient has functional bowel disorders characterized by alternating bowel habits (diarrhea/constipation)
- Patient has secondary constipation (colonic obstruction, medications, metabolic cause)
- Patient has any other condition that, in the opinion of the investigator, may adversely affect the compliance or safety of the patient or would limit the patient's ability to complete the study.
- Patient has any of the contraindications listed below:
- Cardiac: Congestive heart failure (NYHA class III or IV or EF \<50%)
- GI: Intestinal perforation, carcinoma of the rectum, fissures or fistula, severe hemorrhoids, abdominal hernia, recent colon or rectal surgery, or abdominal surgery
- GU: Renal insufficiency (CC \< 60 ml/min/173m2), cirrhosis with ascites
- Abdominal surgery within the last 6 months
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- HyGIeaCare, Inc.lead
- Biostatistical Consulting, Inc.collaborator
Study Sites (1)
Mayo Clinic
Scottsdale, Arizona, 85259, United States
Related Publications (2)
Crowell MD, Umar SB, Lacy BE, Jones MP, DiBaise JK, Talley NJ. Multi-Dimensional Gastrointestinal Symptom Severity Index: Validation of a Brief GI Symptom Assessment Tool. Dig Dis Sci. 2015 Aug;60(8):2270-9. doi: 10.1007/s10620-015-3647-3. Epub 2015 Apr 5.
PMID: 25842355BACKGROUNDSommers T, Corban C, Sengupta N, Jones M, Cheng V, Bollom A, Nurko S, Kelley J, Lembo A. Emergency department burden of constipation in the United States from 2006 to 2011. Am J Gastroenterol. 2015 Apr;110(4):572-9. doi: 10.1038/ajg.2015.64. Epub 2015 Mar 24.
PMID: 25803399RESULT
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
Sarah Umar, MD
Mayo Clinic
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 30, 2017
First Posted
November 8, 2017
Study Start
March 1, 2018
Primary Completion
March 1, 2019
Study Completion
March 1, 2019
Last Updated
September 23, 2019
Record last verified: 2019-03